Lucid Diagnostics Files 8-K on Corporate Actions
Ticker: LUCD · Form: 8-K · Filed: Jul 24, 2024 · CIK: 1799011
Sentiment: neutral
Topics: corporate-governance, filing, financial-reporting
TL;DR
Lucid Diagnostics filed an 8-K on July 23, 2024, covering corporate changes and financial updates.
AI Summary
On July 23, 2024, Lucid Diagnostics Inc. filed an 8-K report detailing several corporate actions. The filing includes amendments to its articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 360 Madison Avenue, New York, NY.
Why It Matters
This 8-K filing indicates significant corporate governance and financial reporting activities for Lucid Diagnostics Inc., which could impact its operational structure and investor relations.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain any immediate negative financial or operational news.
Key Players & Entities
- Lucid Diagnostics Inc. (company) — Registrant
- July 23, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 360 Madison Avenue, 25th Floor, New York, New York 10017 (address) — Principal Executive Offices
- (917) 813-1828 (phone_number) — Registrant's telephone number
FAQ
What specific amendments were made to Lucid Diagnostics Inc.'s articles of incorporation or bylaws?
The filing indicates amendments were made, but the specific details of these amendments are not provided in the summary text of the 8-K.
What matters were submitted to a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but the nature of these matters is not detailed in the provided text.
What financial statements and exhibits are included in this filing?
The filing mentions the submission of financial statements and exhibits, but their specific content is not described in the provided summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 23, 2024.
Where are Lucid Diagnostics Inc.'s principal executive offices located?
Lucid Diagnostics Inc.'s principal executive offices are located at 360 Madison Avenue, 25th Floor, New York, New York 10017.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 24, 2024 regarding Lucid Diagnostics Inc. (LUCD).